Seroprevalence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) In District Vehari, Pakistan

被引:0
作者
Ahmed, Muhammad Zeeshan [1 ,2 ]
Shahzad, Haseeba [1 ]
Rao, Tazeen [1 ]
Ali, Aleema [1 ]
Samad, Noreen [1 ]
机构
[1] Bahauddin Zakariya Univ, Dept Biochem, Bosan Rd, Multan, Pakistan
[2] Univ Punjab, Inst Biochem & Biotechnol, Quaid I Azam Campus, Lahore, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 05期
关键词
Seroprevalence; Hepatitis C virus; Hepatitis B virus; Pakistan;
D O I
10.29271/jcpsp.2020.5.550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to evaluate the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) in district Vehari, Pakistan; and to highlight the alarming situation of HCV. This survey was conducted in the district from June to August 2018. A total of 697 (72.99%) cases out of 955, were found to be infected with hepatitis viruses, among which, 681 (71.3%) were infected with HCV and 16 (1.68%) with HBV. HCV was found more prevalent in females while more cases of HBV were reported in males. Overall age ranged from 31 to 60 years, with females from 51-60 years; infected with HCV and HBV in male with age range 19-30 years infected with HBV. The situation of the seroprevalence of HCV is alarming and the authorities in Pakistan should take extensive measures for the elimination of the hepatitis viruses from Pakistan.
引用
收藏
页码:550 / 551
页数:2
相关论文
共 6 条
[1]  
Akhtar H, 2018, ADVAN LIFE SCI, V5, P46
[2]  
Al Kanaani Z., 2018, ROY SOC OPEN SCI, V5, DOI DOI 10.1098/rsos.180257
[3]   Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination [J].
Lim, Aaron G. ;
Qureshi, Huma ;
Mahmood, Hassan ;
Hamid, Saeed ;
Davies, Charlotte F. ;
Trickey, Adam ;
Glass, Nancy ;
Saeed, Quaid ;
Fraser, Hannah ;
Walker, Josephine G. ;
Mukandavire, Christinah ;
Hickman, Matthew ;
Martin, Natasha K. ;
May, Margaret T. ;
Averhoff, Francisco ;
Vickerman, Peter .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) :550-560
[4]  
Munir A, 2016, INT J BIOTECHNOL ALL, V4, P421
[5]  
Qasim M., 2010, NEWS
[6]  
WHO, 2018, PAK INV HEP MAY SEE